Pfizer (Germany) Today

PFE Stock  EUR 23.79  0.27  1.15%   

Performance

Very Weak

 
Weak
 
Strong

Odds Of Distress

Low

 
High
 
Low
Pfizer is selling at 23.79 as of the 13th of March 2025; that is 1.15 percent increase since the beginning of the trading day. The stock's lowest day price was 23.66. Pfizer has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 13th of December 2024 and ending today, the 13th of March 2025. Click here to learn more.
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Pfizer Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Pfizer's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Pfizer or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Business ConcentrationOther, Other (View all Sectors)
Pfizer Inc (PFE) is traded on Hamburg Exchange in Germany . The company operates under Other sector and is part of Other industry. Pfizer generates positive cash flow from operations, but has no cash available
Check Pfizer Probability Of Bankruptcy

Pfizer Inc Risk Profiles

Although Pfizer's alpha and beta are two of the key measurements used to evaluate Pfizer's performance over the market, the standard measures of volatility play an important role as well.

Pfizer Stock Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in Pfizer without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Suggestion Now

   

Portfolio Suggestion

Get suggestions outside of your existing asset allocation including your own model portfolios
All  Next Launch Module

Additional Information and Resources on Investing in Pfizer Stock

When determining whether Pfizer Inc is a strong investment it is important to analyze Pfizer's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pfizer's future performance. For an informed investment choice regarding Pfizer Stock, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pfizer Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Please note, there is a significant difference between Pfizer's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pfizer is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pfizer's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.